Jeffrey Epstein Emails: Pam Bondi Responds to Trump’s FBI Request

Donald Trump faces the prospect of a Republican rebellion when the U.S. House votes on releasing the Epstein files next week ...

NGEx Reports Q3 2025 Results; Focus on Lunahuasi Exploration Following Successful Financing and Spin-out

NGEx Minerals Ltd. ("NGEx Minerals" "NGEx" or the "Company") (TSX: NGEX) (OTCQX: NGXXF) is pleased to report its results for ...

Databricks: 'PDF parsing for agentic AI is still unsolved' — new tool replaces multi-service pipelines with single function

The company this week detailed its "ai_parse_document" technology, now integrated with Databricks' Agent Bricks platform. The ...

Google’s NotebookLM Update Adds Deep Research, Expanded File Formats

Google’s latest release raises the platform’s research capabilities with structured analysis, clear sourcing, and support for ...

Columbus City Schools outlines possible staffing cuts to close $50 million budget gap

Columbus City Schools leaders say they’re facing some of the toughest decisions the district has seen in years.

Gemini File Search : Is It Worth It for RAG in 2025, or Too Limited for Teams?

See where Gemini File Search helps quick RAG builds and where it falls short, from metadata extraction to hybrid search and transparency concerns ...

NotebookLM now speaks Sheets, Word, PDFs, and images for your research

NotebookLM’s latest update adds Deep Research and support for Sheets, Word, PDFs, and images, turning Google’s AI notebook ...

Lundbeck files for marketing authorization across key Asian markets for Vyepti® (eptinezumab) for the preventive treatment of migraine

H. Lundbeck A/S (Lundbeck) today announced the acceptance of its new drug application (NDA) for Vyepti® (eptinezumab) by the Ministry of Health, Labor and Welfare (MHLW) in Japan.